abstract |
Described herein are compounds that modulate 5-lipoxygenase-activated protein (FLAP), and pharmaceutical compositions containing the compounds. Also described herein are methods of using the above FLAP modulators alone and in combination with other compounds to treat respiratory, cardiovascular and other leukotriene-dependent or leukotriene mediated conditions or diseases. |